Shilpa Medicare receives USFDA approval for Azacitidine Injection

04 Oct 2016 Evaluate

Shilpa Medicare has received an approval from the United States Food & Drug Administration (USFDA) for Azacitidine - Injection ANDA of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

537.75 -7.75 (-1.42%)
29-Apr-2024 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1523.70
Dr. Reddys Lab 6275.60
Cipla 1401.00
Zydus Lifesciences 965.35
Lupin 1640.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.